Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Ralf Stemkens und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Antitubercular Agents, Quality Control. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Radboudumc, Nijmegen, The Netherlands.
Abstract (Originalsprache)
Objectives
Participation in an external (interlaboratory) quality control (QC) programme is an essential part of quality assurance as it provides laboratories with valuable insights into their analytical performance. We describe the 10 year results of an international QC programme for the measurement of anti-tuberculosis (TB) drugs.
Methods
Each year, two rounds were organized in which serum (or plasma) samples, spiked with known concentrations of anti-TB drugs, were provided to participating laboratories for analysis. Reported measurements within 80%–120% of weighed-in concentrations were considered accurate. Mixed model linear regression was performed to assess the effect of the measured drug, concentration level, analytical technique and performing laboratory on the absolute inaccuracy.
Results
By 2022, 31 laboratories had participated in the QC programme and 13 anti-TB drugs and metabolites were included. In total 1407 measurements were reported. First-line TB drugs (isoniazid, rifampicin, pyrazinamide and ethambutol) represented 58% of all measurements. Overall, 83.2% of 1407 measurements were accurate, and the median absolute inaccuracy was 7.3% (IQR, 3.3%–15.1%). The absolute inaccuracy was related to the measured anti-TB drug and to the performing laboratory, but not to the concentration level or to the analytical technique used. The median absolute inaccuracies of rifampicin and isoniazid were relatively high (10.2% and 10.9%, respectively).
Conclusions
The 10 year results of this external QC programme illustrate the need for continuous external QC for the measurement of anti-TB drugs for research and patient care purposes, because one in six measurements was inaccurate. Participation in the programme alerts laboratories to previously undetected analytical problems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Clinical Pharmacy, OLVG Hospital, 1066 CX Amsterdam, The Netherlands.
- Drug Analysis and Toxicology section (KKGT), Dutch Foundation for Quality Assessment in Medical Laboratories (SKML), Nijmegen, The Netherlands.
- Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
- Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
- The University of Sydney Institute for Infectious Diseases, Sydney, NSW, Australia.
ORCID-Profile: Ralf Stemkens, Jan-Willem Alffenaar, Marieke G G Sturkenboom
Förderung
- Radboudumc, Nijmegen, The Netherlands
Zitieren
APA
Stemkens, R., Mouhdad, C., Franssen, E. J. F., Touw, D., Alffenaar, J. W., Te Brake, L. H. M., Sturkenboom, M. G. G., & Aarnoutse, R. E. (2024). Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae105
Vancouver
Stemkens R, Mouhdad C, Franssen EJF, Touw D, Alffenaar JW, Te Brake LHM, et al. Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae105
BibTeX
@article{Stemkens2024,
author = {Stemkens, Ralf and Mouhdad, Chaima and Franssen, Eric J F and Touw, Daniel and Alffenaar, Jan-Willem and Te Brake, Lindsey H M and Sturkenboom, Marieke G G and Aarnoutse, Rob E},
title = {Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae105}
}
EUVIMED